0.74%| Prev Close: | 0.16 |
|---|---|
| Open: | 0.16 |
| Bid: | 0.15 |
| Ask: | 0.16 |
| 1y Target Est: | N/A |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | 0.16 - 0.16 |
|---|---|
| 52wk Range: | 0.14 - 0.60 |
| Volume: | 17,300 |
| Avg Vol (3m): | 93,492 |
| Market Cap: | 2.29M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- Stem Cell Therapeutics Begins Trading on OTCQX®PR Newswire(Mon May 20)
- Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX MarketplaceMarketwired(Thu May 16)
- Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX MarketplaceMarketwired(Thu May 16)
- Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain SyndromeMarketwired(Thu May 16)
- Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain SyndromeMarketwired(Thu May 16)
- Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell ProgramMarketwired(Wed Apr 17)
- Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell ProgramMarketwired(Wed Apr 17)
- Stem Cell Therapeutics Completes Trillium Merger and Issues Stock OptionsMarketwired(Tue Apr 9)
- Stem Cell Therapeutics Completes Trillium Merger and Issues Stock OptionsMarketwired(Tue Apr 9)
- Stem Cell Therapeutics Provides Corporate Update on Acquisitions and FinancingMarketwired(Thu Mar 28)
- Stem Cell Therapeutics Provides Corporate Update on Acquisitions and FinancingMarketwired(Thu Mar 28)
- Stem Cell Therapeutics Closes $3.1 Million FinancingMarketwired(Fri Mar 15)
- Stem Cell Therapeutics Announces Filing of Prospectus Supplement for Proceeds Up to $3.5 Million of UnitsMarketwired(Tue Mar 12)
- Stem Cell Therapeutics Announces Offering of Up to $3.5 Million of UnitsMarketwired(Thu Mar 7)
- REPEAT: Stem Cell Therapeutics Announces Joint-Venture Agreement With Reneu Inc. and Nexgen Medical Systems, IncMarketwired(Wed Feb 20)
Press Releases
- Stem Cell Therapeutics Begins Trading on OTCQX®PR Newswire(Mon May 20)
- Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX MarketplaceMarketwired(Thu May 16)
- Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX MarketplaceMarketwired(Thu May 16)
Must Read
- Japan's top leaders defend 'Abenomics' economic strategies as roiled markets settleThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Oil falls below $94 on weak economic outlook, lukewarm demandThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Sears reports bigger-than-expected loss for 1st quarterThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Gap's 1st-quarter net income rises 43 per cent on strong sales as turnaround continuesThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Ralph Lauren's 4Q profit rises 35 pct, but posts sales shortfallThe Canadian Press(1969-12-31T18:59:59GMT-05:00)